BCL2 and central nervous system cancer: This lncRNA negatively regulates miR-136-5p by binding as a ceRNA, thereby inhibiting Bcl-2 and Wnt2, which act downstream of the PI3K/Akt/mTOR signaling pathway, thus enhancing the glioma malignancy [41].